Koers Opexa Therapeutics Inc Nasdaq
Aandelen
US68372T2024
Biotechnologie & Medisch Onderzoek
Recentste transcriptie over Opexa Therapeutics Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 01-06-21 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | 17/11 |
Joshua Schafer
BRD | Director/Board Member | 53 | 17/11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,61% | 122 mld. | |
+17,75% | 112 mld. | |
+17,23% | 25,91 mld. | |
-24,11% | 19,33 mld. | |
-18,56% | 16,17 mld. | |
-18,47% | 15,56 mld. | |
-47,75% | 14,65 mld. | |
+57,35% | 14,34 mld. | |
+5,62% | 14 mld. |